Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Egetis Therapeutics Major Shareholding Notification 2021

Apr 15, 2021

3152_iss_2021-04-15_04dea7a2-c3b4-4bda-817d-271bee076365.pdf

Major Shareholding Notification

Open in viewer

Opens in your device viewer

Issuer Egetis Therapeutics AB (publ)

Holder

Skandinaviska Enskilda Banken AB

Instrument

Instrument Common stocks SE0003815604
Before the transaction
Shares 9,755,483
Voting rights 9,755,483
Transaction
Reason for major shareholding notification Sell
Date 13/04/2021
Limit for number of shares 5 %
Limit for number of votes 5 %
After the transaction
Quantity
Shares 7,975,125
Directly held voting rights 0
Indirectly held voting rights 7,975,125
Percentage
Directly held shares 4.8314 %
Directly held voting rights 0 %
Indirectly held voting rights 4.8314 %

Resulting distribution of total holdings

Percentage of voting
rights:
Number of underlying
shares:
Shares 4.8314 % 7,975,125
Instruments - FITA Ch. 4, section 2, first
paragraph, line 2
Instruments - FITA Ch. 4, section 2,
first paragraph, line 3
- Physically settled
- Cash settled
Total 4.8314 % 7,975,125

Chain of controlling companies

Voting rights % Voting rights Company
582,688 0.353 Gamla Livförsäkringsaktiebolaget SEB Trygg Liv
7,392,437 4.4784 SEB Life International Assurance Company Ltd
Group
total
holdings
Voting rights 7,975,125
Percentage of voting rights 4.8314

Published

15/04/2021 10:57

Contact

Name Inga Brutane
Phone +46 8 522 296 10 Email [email protected]

[email protected] Tfn 08-408 980 37 Fax 08-24 39 25